We are live on ! Find out more
JUNS

Jupiter Neurosciences
JUNS

7 hedge funds and large institutions have $231K invested in Jupiter Neurosciences in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

324% more capital invested

Capital invested by funds: $54.3K → $231K (+$176K)

250% more funds holding

Funds holding: 2 → 7 (+5)

0.02% more ownership

Funds ownership: 0% → 0.02% (+0.02%)

Holders
7
Holders Change
+5
Holders Change %
+250%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$294K
2
Citigroup
Citigroup
New York
+$233K
3
TSS
Two Sigma Securities
New York
+$148K
4
Two Sigma Investments
Two Sigma Investments
New York
+$47.1K
5
HF
HRT Financial
New York
+$32.1K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$6K

JUNS Hedge Fund Activity: Q1 2025 in Review

7 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Jupiter Neurosciences (JUNS) for Q1 2025, worth a combined $231K — up 324% from $54.3K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new JUNS positions and 1 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $294K. The largest seller was Morgan Stanley, exiting entirely with an estimated $6K sold.

  • 7 institutional investors held Jupiter Neurosciences (JUNS) as of Q1 2025, up from 2 in Q4 2024.
  • Funds reported $231K of Jupiter Neurosciences stock for Q1 2025, up 324% quarter-over-quarter.
  • 6 funds opened new Jupiter Neurosciences positions in Q1 2025 and 1 closed out, a net change of +5 holders.
  • The largest Jupiter Neurosciences buyer in Q1 2025 was UBS Group, an estimated $294K added.
  • The largest Jupiter Neurosciences seller in Q1 2025 was Morgan Stanley, an estimated $6K sold.

Based on aggregated 13F filings for Q1 2025.